Given the evidence displayed earlier, deregulation of Nampt from disruption of circadian factors has been identified as a potential cause for reduced levels of NAD+, and Nampt expression has been found to decrease with age and in heart failure models (12, 39). The gene discussed is NAMPT; the disease is heart failure.